Tandem misses on Q1 earnings, beats rev estimates

Shares in Tandem Diabetes (NSDQ:TNDM) fell today after the medical device maker missed earnings expectations on Wall Street with its 1st quarter results, but beat revenue estimates.

The San Diego-based company posted losses of -$23.8 million, or -75¢ per share, on sales of $18.9 million for the 3 months ended March 31, for bottom-line loss of -13.9% on sales loss of -6% compared with the same period last year.

Get the full story at our sister site, Drug Delivery Business News.

The post Tandem misses on Q1 earnings, beats rev estimates appeared first on MassDevice.

from MassDevice http://ift.tt/2oBr26c